Title
|
Journal
|
Year
|
|
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
|
|
|
|
Lecanemab in Early Alzheimer's Disease
|
|
|
|
Plasma biomarkers for diagnosis of Alzheimer’s disease and prediction of cognitive decline in individuals with mild cognitive impairment
|
|
|
|
A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
|
|
|
|
AZ-4217: A high potency BACE inhibitor displaying acute central efficacy in different In vivo models and reduced amyloid deposition in Tg2576 mice.
|
|
|
|
View All
|